Aerosol formulations containing P134a and particulate medicament

Details Aerosol formulations containing P134a and particulate medicament Aerosol formulations containing P134a and particulate medicament

1995-06-05

1998-04-28

Bawa, Raj

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

424 46, 514826, A61K 912

Patent

active

057441235

ABSTRACT:
This invention relates to aerosol formulations of use for the administration of medicaments by inhalation, in particular a pharmaceutical aerosol formulation which comprises particulate medicament and a fluorocarbon or hydrogen-containing chlorofluorocarbon propellant, which formulation is substantially free of surfactant and with the proviso that said medicament is other than salmeterol, salbutamol, fluticasone propionate, beclomethasone dipropionate or a physiologically acceptable salt or solvate thereof. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of a pharmaceutical aerosol formulation as defined is also described.

REFERENCES:
patent: 2868691 (1959-01-01), Porush et al.
patent: 2885427 (1959-05-01), Rob et al.
patent: 3014844 (1961-12-01), Thiel et al.
patent: 3219533 (1965-11-01), Mullins
patent: 3320125 (1967-05-01), Grim
patent: 3809294 (1974-05-01), Torgeson
patent: 3897779 (1975-08-01), Hansen
patent: 4044126 (1977-08-01), Cook et al.
patent: 4174295 (1979-11-01), Bargigia et al.
patent: 4347236 (1982-08-01), Tanskanen
patent: 4405598 (1983-09-01), Brown
patent: 4814161 (1989-03-01), Jinks et al.
patent: 5118494 (1992-06-01), Schultz et al.
patent: 5126123 (1992-06-01), Johnson
patent: 5182097 (1993-01-01), Byron et al.
patent: 5190029 (1993-03-01), Byron et al.
patent: 5202110 (1993-04-01), Dalby et al.
patent: 5225183 (1993-07-01), Purewal et al.
patent: 5605674 (1997-02-01), Purewal et al.
patent: 5658549 (1997-08-01), Akehurst et al.
patent: 5674471 (1997-10-01), Akehurst et al.
patent: 5674473 (1997-10-01), Purewal et al.
patent: 5681545 (1997-10-01), Purewal et al.
patent: 5683677 (1997-11-01), Purewal et al.
patent: 5695743 (1997-12-01), Purewal et al.
A. R. Gennaro. (1985). Remington's Pharmaceutical Sciences. Mack Pub. Co., Penn., pp. 1670-1677.
Oberholz, Frankfurter Allgemeine Zeitung, Oct. 1989, vol. 25, No. 207, p. 7.
Dalby et al., Pharmaceutical Technology, Mar. 1990, vol. 14, No. 3, pp. 26-33.
Amzacort.TM. carton, William H. Rorer, Inc., Fort Washington, Pennsylvania, USA 19034, 1986.
Pharmaceutical Journal, Sep. 29, 1990, vol. 245, pp. 428-429,.
The Theory and Practice of Industrial Pharmacy, 2nd Ed., 1976 (Philadelphia, PA: Lea and Febiger), pp. 270 and 276-278.
Handbook of Aerosol Technology, 2nd Edition, 1979 (New York, New York: Van Nostrand Reinhold Company), pp. 30, 32, 33, 166, 167, 232, 233.
U.S. Senate Hearings, 12-14 May 1987, 343-347, 437 (U.S. Government Printing Offic, Washington, D.D., 1987), CIS:1987-S321-26.
Hagers Handbook of Pharmaceutical Practice, 1971, pp. 342-354 (Berlin: Springer-Verlag).

Affiliated with

Also associated with

Rating

Aerosol formulations containing P134a and particulate medicament does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aerosol formulations containing P134a and particulate medicament, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aerosol formulations containing P134a and particulate medicament will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1529749